Godrej Agrovet Limited has informed the Exchange regarding a press release dated April 30, 2026, titled "Press Release for the Quarter and financial year ended March 31, 2026.".
GODREJAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Godrej Agrovet Limited (GAVL) reported FY26 consolidated revenue of Rs. 10,233 crore, crossing the Rs. 10,000 crore milestone for the first time and growing 9% YoY from Rs. 9,383 crore. Profit before tax (excluding non-recurring items) grew 17% to Rs. 569 crore vs Rs. 485 crore in FY25. Q4 FY26 revenue was Rs. 2,333 crore (up 9% YoY) and Q4 PBT was Rs. 87 crore (up 18% YoY). Key growth drivers were Oil Palm (segment results up ~68% YoY) and Animal Nutrition (volumes up ~12%, with cattle feed up 18%). Astec LifeSciences achieved EBITDA break-even, turning around from prior losses. Godrej Foods Limited increased branded revenue salience to >80%. Working capital reduction drove improved operating cash flows and ROCE.
GAVL delivered a strong FY26 with revenue crossing Rs 10,000 crore and 17% profit growth, driven by robust performance in Oil Palm and Animal Nutrition. The stock appears well-positioned with improving cash flows, turnaround in Astec LifeSciences, and a strategic shift toward higher-margin branded businesses in poultry and dairy.